These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4427109)

  • 1. Modification of the caffeine-induced locomotor stimulation by a cholinergic mechanism.
    Waldeck B
    J Neural Transm; 1974; 35(3):197-205. PubMed ID: 4427109
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethanol and caffeine: a complex interaction with respect to locomotor activity and central catecholamines.
    Waldeck B
    Psychopharmacologia; 1974 Apr; 36(3):209-20. PubMed ID: 4846326
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitization by caffeine of central catecholamine receptors.
    Waldeck B
    J Neural Transm; 1973; 34(1):61-72. PubMed ID: 4714594
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of caffeine on locomotor activity and central catecholamine mechanisms: a study with special reference to drug interaction.
    Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 4):1-23. PubMed ID: 1080339
    [No Abstract]   [Full Text] [Related]  

  • 5. Postnatal development of benztropine-induced locomotor stimulation: evidence for an anticholinergic mechanism of action.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):313-20. PubMed ID: 4734004
    [No Abstract]   [Full Text] [Related]  

  • 6. Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
    Carlsson M; Carlsson A
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):317-22. PubMed ID: 2557047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between beta-phenylethylamine and agents which affect the cholinergic nervous system on locomotor activity and toxicity in mice.
    Jackson DM
    Arzneimittelforschung; 1974 Jan; 24(1):24-7. PubMed ID: 4406104
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism of tremorine-induced tremor by serotoninergic agents in mice. Interactions with levodopa.
    Rodríguez R
    Life Sci I; 1972 Jun; 11(11):535-44. PubMed ID: 4540331
    [No Abstract]   [Full Text] [Related]  

  • 9. The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
    Hill MP; Brotchie JM
    Br J Pharmacol; 1999 Dec; 128(7):1577-85. PubMed ID: 10602339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 12. Omega conotoxin and prejunctional modulation of the biphasic response of the rat isolated urinary bladder to single pulse electrical field stimulation.
    Maggi CA
    J Auton Pharmacol; 1991 Oct; 11(5):295-304. PubMed ID: 1721069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimuscarinic drugs--effect on brain acetylcholine and tremors in rats.
    Sethy VH; Van Woert MH
    Biochem Pharmacol; 1973 Nov; 22(21):2685-91. PubMed ID: 4763603
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of clonidine on locomotor activity in mice.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Life Sci I; 1972 May; 11(10):483-91. PubMed ID: 4676386
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricted to D2 agonists.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):133-42. PubMed ID: 7710665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Johnels B
    Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
    Goldstein JM; Barnett A; Malick JB
    Eur J Pharmacol; 1975 Aug; 33(1):183-8. PubMed ID: 1175684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of noradrenaline, 5-hydroxytryptamine and acetylcholine in imipramine-induced seizures in mice.
    Amabeoku GJ
    Experientia; 1993 Oct; 49(10):859-64. PubMed ID: 8224101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
    Engström G; Svensson TH; Waldeck B
    Brain Res; 1974 Sep; 77(3):471-83. PubMed ID: 4855210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.